Drug Discovery

Loading the player...

DECLARE-TIMI 58 Commentary

Eric Peterson, MD, chair of the program committee for Scientific Sessions 2018, comments on the results of the DECLARE TIMI 58 trial which was presented at the meeting in Chicago this year.

Science NewsView All Science News

ISC 2019 Science News
02/05/2019 | AHA's Science News for ISC 2019 in Honolulu, Hawaii, Feb. 6-8, 2019. In-depth interviews and a deep-dive look into studies presented at t...
CIRCULATION: CARDIOVASCULAR QUALITY & OUTCOMES 2018 Altmetrics Top Articles
01/16/2019 | CIRCULATION: CARDIOVASCULAR QUALITY AND OUTCOMES 2018 Altmetrics Top Articles
HYPERTENSION | Trending Topics | December 2018
01/10/2019 | Hypertension Trending Topics for December 2018

Related Councils

Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB)

Mary Sorci-Thomas, PhD, FAHA

The Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) contributes to the mission and objectives of the American Heart Association (AHA) through efforts in the fields of arteriosclerosis, thrombosis and vascular biology. The council advances and coordinates research, addresses prevention, improves methods for diagnosis and treatment, and works actively with other organizations concerned with these issues. The council disseminates reliable information related to these fields through its annual conference, many awards and lectures, and the AHA's journal, Arteriosclerosis, Thrombosis, and Vascular Biology.

Mary Sorci-Thomas, PhD, FAHA
Chair, Council on Arteriosclerosis, Thrombosis and Vascular Biology

Vascular Discovery Scientific Sessions       Arteriosclerosis, Thrombosis, and Vascular Biology       ATVB Council Awards

Council on Clinical Cardiology (CLCD)

Randal J. Thomas, MD MS FAHA FACC MAACVPR

The purpose of the Council on Clinical Cardiology (CLCD) is to achieve the objectives of the American Heart Association (AHA) in the field of clinical cardiology, to promote excellence in clinical care and to foster the professional development and education of clinical cardiologists. Through council-sponsored symposia, panels and scientific conferences, members can access new developments in the field and interpret and promote clinical cardiology to professional and lay audiences.

Randal J. Thomas, MD, MS, FAHA, FACC, MAACVPR
Chair, Council on Clinical Cardiology

Scientific Sessions       Circulation       CLCD Council Awards

Council on Genomic and Precision Medicine (GPM)

Thomas J. Wang, MD, FAHA

The mission of the American Heart Association Council on Genomic and Precision Medicine (GPM) is to advance the discovery and translation of biological insights gained from genetics and omics technologies to improve cardiovascular and brain health. Our constituency’s expertise spans across genetics, genomics, epigenetics, transcriptomics, metabolomics, proteomics, microbiome, bioinformatics, computational science, population health, clinical genetics and genomic medicine, with the ultimate goal of more precise risk prediction, treatment and prevention for patients and the population. Integral to the American Heart Association’s goals, the GPM Council provides a premier inter-disciplinary forum promoting and integrating new knowledge from molecules to populations in translational cardiovascular science and precision medicine.

Thomas J. Wang, MD, FAHA
Chair, Council on Genomic and Precision Medicine

Scientific Sessions       Circulation: Genomic and Precision Medicine      GPM Council Awards